Antiplatelet Therapy Practice Test

These questions are part of the practice quiz. Start practicing

• Which finding is a contraindication to initiating clopidogrel therapy?
• What is the standard dual antiplatelet therapy combination after stent placement?
• A patient starting clopidogrel is at risk for which condition?
• Which regimen best summarizes antiplatelet therapy for an ACS patient undergoing PCI?
• Which two adverse effects are commonly associated with aspirin?
• What is the approximate time to onset for ticagrelor after a loading dose?
• What is a clinically important drug interaction between clopidogrel and a common acid-suppressing agent?
• Dipyridamole is commonly used with aspirin for what purpose?
• An acute coronary syndrome patient is prescribed an oral 300-mg clopidogrel as a one-time dose. What should the nurse do?
• What is the typical ticagrelor regimen after loading?
• Which statement best describes the time course of clopidogrel's effect after discontinuation?
• What is a typical loading dose for clopidogrel in ACS management?
• Which scoring tool is designed to assess bleeding risk to guide DAPT duration?
• Before elective surgical procedures, clopidogrel should be stopped how many days in advance?
• Tirofiban belongs to which class of antiplatelet agents?
• What is the role of platelet transfusion in reversing antiplatelet effects?
• Prasugrel is contraindicated in which patient history?
• What is the role and typical use of cangrelor in antiplatelet therapy?
• Which antiplatelet agent is administered intravenously and used during PCI for rapid onset?
• Which finding would indicate a potential bleeding complication in a patient taking clopidogrel?
• Which of the following is a prophylactic use of antiplatelet therapy?
• For patients with poor clopidogrel response due to CYP2C19 polymorphisms, which agents are most appropriate?
• How should the duration of dual antiplatelet therapy be determined after ACS treated with PCI?
• Regarding pregnancy and lactation, what is the guidance for clopidogrel use?
• Which of the following is not a P2Y12 inhibitor?
• What is the general approach to major bleeding in a patient on antiplatelet therapy?
• Which pair constitutes irreversible P2Y12 inhibitors?
• In ACS managed with a drug-eluting stent, what is the typical recommended duration of dual antiplatelet therapy (DAPT)?
• Before urgent surgery, how many days should clopidogrel be held?
• Which P2Y12 inhibitor is typically started with a 60 mg loading dose?
• Aspirin is an example of an antiplatelet that works by inhibiting which enzyme?
• Clopidogrel is absorbed in which part of the gastrointestinal tract?
• A patient is started on clopidogrel and reports hematuria to the nurse before receiving the morning dose. What action should the nurse take next?
• Which factor would lead to shortening the duration of dual antiplatelet therapy after a drug-eluting stent?
• Which agent is a PAR-1 antagonist rather than a P2Y12 inhibitor?
• Clopidogrel activation is mediated primarily by which enzyme, contributing to variable patient response?
• For a patient on DAPT who requires urgent noncardiac surgery, what is the general management approach?
• Name a key bleeding risk factor to assess before starting antiplatelet therapy.
• Clopidogrel is an example of which class of antiplatelet drugs?
• Which statement describes the onset of clopidogrel after a loading dose?
• Pantoprazole in relation to clopidogrel interaction?
• What are the loading and maintenance doses for ticagrelor?
• If a patient on clopidogrel develops thrombotic thrombocytopenic purpura (TTP), which treatment would you anticipate administering?
• Clopidogrel is rapidly absorbed after oral administration, and this occurs with or without food.
• Which statement correctly characterizes irreversible P2Y12 inhibitors?
• How does aspirin's effect on platelets persist after stopping therapy?
• Which statement best describes clopidogrel’s effect on platelets?
• Which statement about cangrelor is true?
• Which of the following is not a P2Y12 inhibitor?
• What is the relationship between aspirin and P2Y12 inhibitors in antiplatelet therapy after stent placement?
• Vorapaxar safety considerations include contraindication in patients with history of which conditions?
• Which statement about the CRUSADE bleeding risk score is accurate?
• Which P2Y12 inhibitor is contraindicated in patients with a history of stroke or TIA?
• Which receptor do P2Y12 inhibitors antagonize on platelets to prevent ADP-mediated activation?
• Patients managing ACS with clopidogrel should also take which aspirin regimen?
• Clopidogrel is used to prevent blood clots after what events?
• What is the typical lifespan of circulating platelets?
• Which food interaction is noted with clopidogrel?
• Vorapaxar is a PAR-1 antagonist; what safety concern is associated with its use?
• In pregnancy, what is the typical approach to aspirin for preeclampsia prevention?
• What percentage of the clopidogrel dose is available for therapeutic activity after metabolism?
• Which statement about aspirin use in pregnancy is accurate?
• Are routine platelet function tests recommended to guide antiplatelet therapy?
• Which statement about drug interactions with clopidogrel is true?
• What is the primary mechanism of action of aspirin in antiplatelet therapy?
• Which intravenous P2Y12 inhibitor is used during PCI to provide rapid and reversible platelet inhibition?
• Which beverage should be avoided during clopidogrel therapy due to inhibition of metabolic activation?
• Which P2Y12 inhibitor typically requires the longest waiting period before noncardiac surgery?
• Which PDE3 inhibitor is used for intermittent claudication and is contraindicated in heart failure?
• What is the minimum recommended DAPT duration after a bare-metal coronary stent?
• Compared to bare-metal stents, drug-eluting stents typically require what adjustment to DAPT duration?
• Which of the following herbs may increase antiplatelet effects when used with clopidogrel? (Choose the option that lists a herb known to have this interaction)
• A patient who previously reported dyspepsia 2 hours after taking clopidogrel should be advised to take the drug how?
• Ticagrelor is best described as which type of P2Y12 inhibitor?
• Which of the following are reversible P2Y12 inhibitors?
• What is the commonly recommended low-dose aspirin maintenance dose for secondary prevention?
• Are routine platelet function tests recommended to tailor antiplatelet therapy?
• In symptomatic peripheral artery disease, what antiplatelet strategy reduces event risk?
• Which aspirin-related statement is true?
• Which of the following foods is noted to interact with clopidogrel by potentially diminishing its effect?
• Which statement about aspirin is true?
• Clopidogrel is a prodrug. Which enzyme family is primarily responsible for its activation?
• Which antiplatelet agent has a role in reducing thrombotic events in peripheral arterial disease but requires careful bleeding risk assessment?
• Before urgent surgery, how many days should prasugrel be held?
• Which P2Y12 inhibitor is reversible and has a rapid offset, suitable for patients needing quick reversal of antiplatelet effect?
• Thrombotic thrombocytopenic purpura (TTP) as an adverse effect of clopidogrel is most likely to occur within what timeframe?
• Which of the following is an indicated use of clopidogrel therapy?
• In ACS with DES, DAPT duration should be shorter than 12 months if which condition is present?
• What two therapies are standard post-stent therapy?
• How should antiplatelet therapy be adjusted in patients with hepatic impairment?
• Which statement best describes the role of clopidogrel in acute coronary syndrome?
• Which of the following best summarizes the main actions described for antiplatelet drugs?
• After PCI with a bare-metal stent, how does DAPT duration typically compare to DES?
• Platelet transfusion may not fully reverse irreversible P2Y12 inhibitors immediately. This statement is:
• What is the excretion pattern of clopidogrel?
• Which statement best describes antiplatelet drugs?
• In clopidogrel poor metabolizers, which of the following is a viable alternative?
• Dipyridamole is commonly combined with which drug for stroke prevention?
• VerifyNow is used in antiplatelet therapy primarily to do what?
• What is the standard loading and maintenance dosing for prasugrel, and when should the maintenance dose be reduced?
• Clopidogrel is primarily metabolized by which liver enzyme?
• Name the GP IIb/IIIa inhibitors commonly used in PCI.
• Clopidogrel is activated primarily in which organ?
• What is vorapaxar and what is a major safety concern?
• Which monitoring considerations are common for long-term dual antiplatelet therapy (DAPT)?
• Which statement about vorapaxar in peripheral arterial disease is accurate?
• What loading dose of aspirin is often given in acute coronary syndrome?
• When routine medications are resumed after major knee surgery, including clopidogrel, what should the nurse do?
• What is the standard maintenance dose of clopidogrel?
• Clopidogrel is an example of which class of antiplatelet agents?
• What is the typical onset timeframe for clopidogrel's antiplatelet effects?
• Why is adherence critical in DAPT after stent placement?
• What is the primary mechanism of action of aspirin in antiplatelet therapy?
• What is the typical DAPT duration after a drug-eluting stent in contemporary practice?
• Which P2Y12 inhibitor is reversible and has a rapid onset, distinguishing it from clopidogrel and prasugrel?
• If a patient on clopidogrel reports blood in urine or stool, what should the nurse do?
• Compared with a bare-metal stent, a drug-eluting stent generally necessitates what change in the DAPT duration?
• Why might a clinician continue aspirin but stop a P2Y12 inhibitor during noncardiac surgery?
• A patient to receive clopidogrel and aspirin has an altered CYP2C19 gene. What action should the nurse take?
• After lower-extremity revascularization in PAD, which antiplatelet strategy is typical?
• What is the main difference between a loading dose and a maintenance dose in antiplatelet therapy?
• Which agent is not a P2Y12 inhibitor?
• Regarding excretion, which statement is true?
• A nurse is selecting indications for clopidogrel in patients with various cardiac conditions. Which option correctly describes a scenario where clopidogrel would be used?
• Clopidogrel prevents platelet aggregation by which mechanism?
• Dose of clopidogrel is determined by
• Which of the following is a potential adverse reaction to clopidogrel that requires clinician awareness?
• Which history is least likely to indicate prophylactic antiplatelet therapy?
• Which statement accurately describes clopidogrel's use with aspirin?
• A patient is prescribed clopidogrel and aspirin. Which statement about this combination is accurate?
• What is the standard ticagrelor dosing regimen in ACS?
• A patient on clopidogrel on the tenth day presents with a temperature of 102.1°F and total urine output of 200 mL over 24 hours. The patient is disoriented. Which adverse effect would the nurse suspect?
• Which P2Y12 inhibitor is the only oral agent that is reversible?
• Dipyridamole, used in stroke prevention, has which characteristic according to the material?
• Which conditions are encompassed by acute coronary syndrome?
• After drug-eluting stent placement in ACS, what is the typical minimum duration of dual antiplatelet therapy (DAPT)?
• What is the recommended minimum duration of dual antiplatelet therapy after drug-eluting stent placement in ACS, assuming no excessive bleeding risk?
• What is the approximate duration for the restoration of baseline platelet function after stopping clopidogrel?
• Which score helps decide whether to extend DAPT beyond 12 months in ACS?
• Which adverse effect is associated with clopidogrel in the described case?
• If a proton pump inhibitor is needed to prevent GI bleed in clopidogrel-treated patients, which drug is appropriate?
• Which of the following should prompt contacting a health care provider?
• Patients on clopidogrel are instructed not to stop the medication unless instructed by the health care provider. Which statement reflects this guidance?
• Clopidogrel is a prodrug that is activated in which organ?
• What is a key pharmacokinetic property of cangrelor?
• How does dipyridamole work in stroke prevention?
• In patients who are poor metabolizers of clopidogrel, what happens to the antiplatelet effect?
• What is the role of cangrelor in PCI?
• Preoperative management of aspirin in non-cardiac surgery: when is continuation generally considered appropriate?
• Genotyping for CYP2C19 can influence management of clopidogrel therapy by:
• Cilostazol belongs to which class of drugs and what is its mechanism?
• What is the typical maintenance dose of low-dose aspirin used for long-term cardiovascular prevention?
• Which herb is listed as potentially increasing antiplatelet effects when used with clopidogrel?
• Cilostazol is used for which condition, and what is its mechanism?
• Bleeding risks with clopidogrel include which of the following?
• Which agent can be combined with aspirin for stroke prevention?
• In a patient with high bleeding risk, which P2Y12 inhibitor is often preferred due to bleeding profile?
• Which statement best describes ticagrelor's platelet inhibition in relation to CYP2C19 genotype?
• During discharge teaching, a patient using fresh garlic asks about its safety with clopidogrel. Which response is appropriate?
• In the context of urgent noncardiac surgery, what is the recommended course regarding aspirin?
• Which PPI is preferred to minimize interaction with clopidogrel?
• In patients with minor stroke or high-risk TIA, what DAPT strategy has shown benefit in trials, and for how long is it commonly used?
• When switching between P2Y12 inhibitors, loading doses should be given...
• After discontinuing clopidogrel, how many days does it take for platelets to regain baseline function?
• Which finding would warrant medical attention in a patient taking clopidogrel?
• Which drug requires a 180 mg loading dose when initiating therapy for ACS/PCI?
• What is the maintenance dosing frequency for ticagrelor?
• How should dual antiplatelet therapy be managed if urgent surgery is needed?
• Which adverse effect is particularly associated with ticagrelor compared with some other P2Y12 inhibitors?
• After administration, when would the nurse expect clopidogrel to start having its effect?
• Which conditions are cited as examples where antiplatelet prophylaxis may be used?
• What is the recommended management before elective surgery?
• Clopidogrel's effect on bleeding compared with aspirin in clinical trials.
• What is the primary clinical goal of DAPT after stent placement?
• What is a common reason for stopping dual antiplatelet therapy early after PCI?
• Which class do prasugrel and ticagrelor belong to?
• A patient is prescribed clopidogrel and aspirin at 9:00 a.m. What should the nurse do regarding administration timing?
• In noncardioembolic stroke or TIA, which antiplatelet is commonly used as monotherapy?
• What is the approximate time to onset for prasugrel after a loading dose?
• Which antiplatelet therapy is sometimes used as monotherapy for stroke prevention after aspirin failure, though less common?
• Which laboratory changes may be observed with clopidogrel use?
• How many days does it take for platelet aggregation to return to baseline once clopidogrel is discontinued?
• A patient states that clopidogrel is causing an upset stomach. What instruction should the nurse provide?
• Dipyridamole has which mechanism of action, and what is its clinical use?
• Identify high-risk patients for clopidogrel therapy. Which statement is most accurate?
• Which agent is commonly combined with aspirin for non-COX-mediated stroke prevention?
• In patients with coronary artery disease, clopidogrel helps prevent thrombosis. Which choice best expresses this statement?
• What is the typical loading dose of clopidogrel used in ACS/PCI?
• Name a major contraindication to prasugrel therapy.
• Which agent is a reversible P2Y12 inhibitor not a thienopyridine?
• Which agent provides rapid, short-acting platelet inhibition during PCI and can be overlapped with oral P2Y12 inhibitors?
• After ACS treatment, what is the general emphasis of secondary prevention?
• Which agent is contraindicated in patients with a prior stroke or TIA due to elevated risk of intracranial bleeding?
• When switching between P2Y12 inhibitors, what is a key clinical consideration?
• Which statement describes an interaction between clopidogrel and proton pump inhibitors?
• Why are CYP2C19 loss-of-function alleles clinically important for clopidogrel therapy?
• Managing clopidogrel therapy, the reversal of its platelet-inhibiting effect occurs in approximately how many days?
• Which patient scenario requires caution when using clopidogrel due to bleeding risk?
• Which interactions are most likely to increase bleeding risk when used with clopidogrel?
• Are clopidogrel's antiplatelet effects reversible after stopping the drug?
• What is the standard loading dose and maintenance dosing for ticagrelor in ACS?
• Clopidogrel distribution is characterized by which level of protein binding?
• Which agent is an intravenous, reversible P2Y12 inhibitor used during PCI for immediate platelet inhibition?
• Thromboxane A2 in platelet biology primarily promotes what?
• What tablet strengths is clopidogrel available in?
• What strategy helps reduce aspirin-associated GI bleeding risk?
• A nurse is preparing clopidogrel for several patients. Clopidogrel is indicated for which condition?
• Which score helps estimate bleeding risk in patients on DAPT?
• Which enzyme is primarily responsible for activating clopidogrel, contributing to variable patient response?
• Which statement best describes the dosing complexity of aspirin versus P2Y12 inhibitors?
• Which of the following is a recognized adverse reaction to clopidogrel?
• Which statement best describes ticagrelor’s mechanism compared with clopidogrel and prasugrel?
• Clopidogrel inhibits which receptor to prevent platelet aggregation?
• What is true about taking clopidogrel?
• Which statement correctly identifies the reversible nature of ticagrelor?
• What is the approximate onset of the antiplatelet effect after a dose of clopidogrel?
• Which P2Y12 inhibitor commonly causes dyspnea as a side effect?
• Genetic variation in which gene can reduce clopidogrel efficacy due to poor metabolism?
• Which proton pump inhibitor is less likely to interfere significantly with clopidogrel activation?
• Which statement best describes the impact of CYP2C19 genotype on clopidogrel metabolism?
• Which statement about clopidogrel and CYP2C19 polymorphisms is true?
• Which agent irreversibly binds to GP IIb/IIIa receptors producing prolonged antiplatelet effects?
• Are routine platelet function tests recommended to guide antiplatelet therapy decisions in ACS?
• Which laboratory parameter is expected to remain stable in a patient taking clopidogrel?
• Name the three GP IIb/IIIa inhibitors commonly used in PCI.
• Which P2Y12 inhibitors irreversibly inhibit the P2Y12 receptor after activation?
• Ticlopidine has largely fallen out of favor due to risk of which condition?
• What are the typical loading and maintenance doses for clopidogrel in acute coronary syndrome?
• Which risk scoring tool is used to help decide DAPT duration?
• Clopidogrel is indicated for which of the following conditions?
• What is the general goal of dual antiplatelet therapy in ACS?
• How should life-threatening bleeding on antiplatelet therapy be initially managed?
• Which antiplatelet agent is associated with GI risk and should be used cautiously with NSAIDs?
• Name two scenarios where GP IIb/IIIa inhibitors are typically used.
• Which statement correctly contrasts abciximab and eptifibatide regarding binding and duration?
• During Pre-Administration Assessment for Clopidogrel, which item is emphasized if available?
• What is a common reason for clopidogrel 'resistance' and how can it be addressed?
• What should patients do with symptoms while on clopidogrel unless told otherwise?
• When clopidogrel is used to reduce atherosclerotic events following an MI, stroke, or PAD, what regimen is given?
• Clopidogrel activation in the liver is primarily mediated by which cytochrome P450 enzyme?